A double-blind, placebo-controlled study of 80 colicky infants showed that the crying time was significantly reduced among the infants supplemented by drops with the probiotic Lactobacillus reuteri Protectis compared to those in the placebo group. The quality of life for the parents and families were also significantly improved in the probiotic group compared to the placebo group.
The study was done by Hania Szajewska who is professor and chair of the Department of Paediatrics at the Medical University of Warsaw in Poland. She is one of the most well-reputed experts in probiotics in the world and has conducted numerous clinical trials.
The significant reduction in crying time confirm earlier studies with Lactobacillus reuteri Protectis in infants with colic, but further, and for the first time, the parents perception of the baby’s colic and the quality of life of the parents and the family have been measured. These parameters showed highly significant improvements in the probiotic group as compared to the placebo group. The new study also included colic diagnosed infants that were partially fed with formula, extending the findings of earlier studies, which were performed in exclusively breast-fed infants.
The study was performed according to the highest standards of clinical trial reporting (CONSORT). It was published in The Journal of Pediatrics on Sept. 14, 2012.
“This is the third independent study with Lactobacillus reuteri Protectis in infants and the effectiveness of our product in reducing symptoms of colic is now very clear. This new and strong data further strengthens the position of Lactobacillus reuteri Protectis within the paediatric field,” says Peter Rothschild, president of BioGaia.